Search
Pioglitazone
go.drugbank.com/drugs/DB01132ApprovedInvestigationalPioglitazone is an antihyperglycemic used as an adjunct to diet, exercise, and other antidiabetic medications to manage type 2 diabetes mellitus. … [L11416,L11419,L11422,L11425] It is administered as a racemic mixture, though there is no pharmacologic difference between the enantiomers and they appear to interconvert _in vivo_ with little consequence
Mixtures: PIOGLITAZONE E METFORMINA EG, PIOGLITAZONE E METFORMINA EGCategories: Drugs Used in DiabetesVincristine
go.drugbank.com/drugs/DB00541ApprovedInvestigationalVincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. … It is marketed under several brand names, many of which have different formulations such as Marqibo (liposomal injection) and Vincasar.
Products: VINCRISTINA EG, VINRACINE INJECTION 1MG/1MLTubocurarine
go.drugbank.com/drugs/DB01199ApprovedWithdrawn[A216028] It was first isolated by Harold King in 1935 and was used clinically to induce neuromuscular blockade during surgeries, particularly those involving the abdomen. … [A216048] Safer and more pharmacokinetically favorable non-depolarizing neuromuscular blockers, such as [rocuronium], have largely replaced the use of tubocurarine in the clinical setting.[A216048]
Products: Tubocurarine Chloride Inj 3mg/ml, Tubocurarine Chloride Inj 3mg/ml USPDiclofenac
go.drugbank.com/drugs/DB00586ApprovedInvestigationalVet approvedIt is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. … Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes.
Mixtures: DIFEMIS 50 MG/0.2 MG TABLET, 20 ADET, DIFEMIS 50 MG/0.2 MG TABLET, 30 ADETProducts: DICLOFENAC INFUSION 75MG EN SODIO CLORURO 0.7% POR 100ML, Panamax Patch 60mg/12gFaricimab
go.drugbank.com/drugs/DB15303ApprovedInvestigational[L40026] It received subsequent approval for the same indications in Canada in May 2022. … However, another set of factors, the Tie/Ang axis, comprising the transmembrane Tie-2 receptor and its soluble ligands Ang-1 and Ang-2, has been shown to play critical roles in mediating VEGF-A-induced
Products: VABYSMO 6mg/0.05mL Solution for Intravitreal InjectionDeucravacitinib
go.drugbank.com/drugs/DB16650ApprovedInvestigational[L43150] It was later approved by Health Canada in November 2022 [L44216] and by the European Medicines Agency in March 2023.[L45788] … [A246943] Deucravacitinib was first approved by the FDA in September 2022 to treat moderate-to-severe plaque psoriasis.
Products: SOTYKTU® 6MG TABLETAS RECUBIERTAS, SOTYKTU 6 mg film coated tabletsEverolimus
go.drugbank.com/drugs/DB01590ApprovedInvestigationalIt is currently used as an immunosuppressant to prevent rejection of organ transplants. … In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and not on the mTORC2 protein.
Products: EVEROLIMUS EG, Afinitor 3mg Dispersible TabletLisinopril
go.drugbank.com/drugs/DB00722ApprovedInvestigational[A184781,A184808,A184817] ACEIs are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers. … [A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.
Mixtures: LISAM 10 mg/5 mg Tabletten, LisAm 20 mg/5 mg TablettenCategories: Agents Acting on the Renin-Angiotensin System, Compounds used in a research, industrial, or household settingLercanidipine
go.drugbank.com/drugs/DB00528ApprovedInvestigationalWithdrawnIt is sold under various commercial names including Zanidip.
Mixtures: ZANITEK 10 MG/10MG FILM TABLET,90 ADET, ZANITEK 10 MG/10MG FILM TABLET, 30 ADETProducts: LERCANIDIPINA EG, CARMEN 10MGMethylprednisolone
go.drugbank.com/drugs/DB00959ApprovedInvestigationalVet approved[A188811] It was first described in the literature in the late 1950s.[A188811,A188814] Methylprednisolone was granted FDA approval on 24 October 1957. … [L10785] In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression.
Mixtures: Physicians EZ Use M-pred, Physicians EZ Use M-predCategories: Compounds used in a research, industrial, or household setting